XAI-CNVMarker: Explainable AI-based copy number variant biomarker discovery for breast cancer subtypes
Authors:
- Sheetal RajpalSRSheetal Rajpal
- Ankit RajpalARAnkit Rajpal
- Manoj AgarwalMAManoj Agarwal
- Virendra KumarVKVirendra Kumar
- Ajith AbrahamAAAjith Abraham
- Divya KhannaDKDivya Khanna
- Naveen KumarNKNaveen Kumar
- 26 April 2023
- journal article
- research article
- Published by Elsevier in Biomedical Signal Processing and Control
- Vol. 84
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (WOS-A/LS-350/2017)
This publication has 65 references indexed in Scilit:
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerBreast Cancer Research, 2013
- Pan-cancer patterns of somatic copy number alterationNature Genetics, 2013
- Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast CarcinomasPLOS ONE, 2012
- Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cellsBiochemical Journal, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumEMBO Molecular Medicine, 2011
- ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2Cancer Research, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003